Montefiore Einstein Center for Cancer Care Director Named Editor-In-Chief of Cancer Gene Therapy

News Release

Montefiore Einstein Center for Cancer Care Director Named Editor-In-Chief of Cancer Gene Therapy

Cuerpo

NEW YORK (January 30, 2014) – Steven Libutti, M.D., F.A.C.S., professor and vice chairman in the Department of Surgery at Montefiore Medical Center and Albert Einstein College of Medicine at Yeshiva University, director at the Montefiore Einstein Center for Cancer Care and professor in the Department of Genetics and associate director of clinical services at Albert Einstein College of Medicine has been named Editor-in-Chief of Cancer Gene Therapy, a journal for cancer researchers and clinicians.

Steven Libutti, M.D., F.A.C.S., professor and vice chairman in the Department of Surgery at Montefiore Medical Center and the Albert Einstein College of Medicine at Yeshiva University, director at the Montefiore Einstein Center for Cancer Care and professor in the Department of Genetics and associate director of clinical services at Albert Einstein College of Medicine has been named Editor-in-Chief of Cancer Gene Therapy, a journal for cancer researchers and clinicians.
Steven Libutti, M.D., F.A.C.S.
Cancer Gene Therapy serves as a respected resource for scientists and clinicians on the latest gene and cellular therapies for cancer. Topics will range from DNA synthesis and repair to the latest original laboratory research and case reports on translational research and tumor immunotherapies.

“The progression of personalized cancer treatments and evolution of new technologies for monitoring genetic changes holds new promise for those impacted by cancer,” said Dr. Libutti. “Cancer Gene Therapy will cover innovative scientific developments and prompt clinical questions that I hope spark new perspectives and industry dialogue about what’s next.”

As a pioneer in tumor-targeted gene therapy, Dr. Libutti is developing novel cancer therapies through his study of the complex interactions that occur within a tumor’s microenvironment. Since 2009, he has spearheaded multidisciplinary efforts in research and treatment of cancer at the Montefiore Einstein Center for Cancer Care.

Cancer Gene Therapy will cover innovative scientific developments and prompt clinical questions that I hope spark new perspectives and industry dialogue about what’s next.”

-- Steven Libutti, M.D., F.A.C.S.

“We feel honored to be working in conjunction with an expert of Dr. Libutti’s caliber,” said Andrea Macaluso, publishing manager, Nature Publishing Group. “His vast experience discovering new and effective ways to treat cancer combined with his record of excellent basic research and clinical care made him a natural choice to lead our journal and further strengthen Nature Publishing Group’s library of scientific and medical publications.”

Dr. Libutti is an internationally recognized expert in surgical oncology and endocrine surgery and has published more than 250 peer-reviewed journal articles and 16 oncology book chapters. He has received the NIH Director’s Award and the National Cancer Institute’s Director’s Gold Star and Intramural Innovation Awards. Dr. Libutti also has appeared on Castle Connolly’s list of “Top Doctors in America” and on New York Magazine’s list of “Top Doctors in New York.” In 2009, he was named the Marvin L. Gliedman, M.D., Distinguished Surgeon at Montefiore Medical Center.  Prior to being appointed director of the Montefiore Einstein Center for Cancer Care, Dr. Libutti was a researcher, surgeon and Section Head at the National Cancer Institute.